Q&A with Dr. Shengqing (Stan) Gu: Improving Immunotherapy for Acute Myeloid Leukemia
Shengqing (Stan) Gu, PhD, of the University of Texas MD Anderson Cancer Center, aims to enhance the efficacy of cancer immunotherapy for acute myeloid leukemia (AML) patients.
Blog